128 filings
Page 2 of 7
424B5
x4chvu32if
22 Dec 23
Prospectus supplement for primary offering
4:51pm
8-K
t1awukw
18 Dec 23
Invivyd Announces Positive Initial Results from Ongoing CANOPY Phase 3 Pivotal Clinical Trial
7:16am
8-K
wqedo ldda
9 Nov 23
Invivyd Reports Third Quarter 2023 Financial Results and Recent Business Highlights
4:10pm
8-K
dlymm36 l93old601
11 Sep 23
Other Events
7:10am
8-K
nxi916ysorno347z2c
5 Sep 23
Invivyd Appoints William Duke As Chief Financial Officer
7:05am
8-K
qfjxxhw 55pr6n0n
10 Aug 23
Invivyd Reports Second Quarter 2023 Financial Results and Business Highlights
4:04pm
8-K
9dzbdc1u7 1kna5r
27 Jul 23
Invivyd Announces Appointment of Sara Cotter to Board of Directors
4:06pm
8-K
8xm co30gf3q8
29 Jun 23
Other Events
7:08am
8-K
1ifm3ljw6ftb5n8fk2z
25 May 23
Amendments to Articles of Incorporation or Bylaws
4:20pm
8-K
5vshl
11 May 23
Invivyd Reports First Quarter 2023 Financial Results and Business Highlights
4:08pm
8-K
s9a e578tux521up
2 May 23
Departure of Directors or Certain Officers
7:37am
ARS
3ul0ntja
10 Apr 23
Annual report to shareholders
4:19pm
DEFA14A
5kafs
10 Apr 23
Additional proxy soliciting materials
4:10pm
DEF 14A
36la2za6vq6lty6c
10 Apr 23
Definitive proxy
4:07pm
PRE 14A
20oax2fk2d 4z35jlpy
31 Mar 23
Preliminary proxy
4:36pm
8-K
csjjj a3cp30r7
23 Mar 23
Invivyd Reports Full Year 2022 Financial Results and Business Highlights
4:12pm